Clinical Trial Update: Improving Symptoms of Schizophrenia and Schizoaffective Disorder by Supplementing Medications With Pravastatin [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating whether adding pravastatin to standard treatment improves symptoms in schizophrenia and schizoaffective disorder. The study st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizoaffective Disorder
• Schizophrenia

Drugs mentioned

• Pravastatin (pravastatin)

Snippet

Sponsor: University of Pittsburgh | Conditions: Schizophrenia, Schizoaffective Disorder | Phase 4 | Status: COMPLETED